American Portfolios Advisors’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
PHS
American Portfolios Advisors's EDIT Position: Q3 2022 in Review
American Portfolios Advisors reduced its Editas Medicine (EDIT) stake by 25% in Q3 2022, selling an estimated $4.41K and leaving 867 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2516.
American Portfolios Advisors first reported a position in EDIT in Q1 2018 and has held it in 19 quarters since. The position peaked at $899K in Q4 2020. 265 funds tracked by Wall St. Rank hold EDIT as of Q3 2022.
- American Portfolios Advisors held 867 shares of Editas Medicine worth $10.6K as of Q3 2022.
- American Portfolios Advisors sold 283 Editas Medicine shares in Q3 2022, an estimated $4.41K.
- Editas Medicine made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2516 holding.
- American Portfolios Advisors first reported a position in Editas Medicine in Q1 2018 and has held it in 19 quarters since.
- American Portfolios Advisors's Editas Medicine position peaked at $899K in Q4 2020.
- 265 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.